Nageswararao Muddana

429 total citations
30 papers, 350 citations indexed

About

Nageswararao Muddana is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Nageswararao Muddana has authored 30 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Nageswararao Muddana's work include Cholinesterase and Neurodegenerative Diseases (9 papers), Receptor Mechanisms and Signaling (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). Nageswararao Muddana is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (9 papers), Receptor Mechanisms and Signaling (9 papers) and Neuroscience and Neuropharmacology Research (7 papers). Nageswararao Muddana collaborates with scholars based in India. Nageswararao Muddana's co-authors include Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Vishwottam Kandikere, Ramanatha Saralaya, Vijay Benade, Koteshwara Mudigonda, Pradeep Jayarajan, Renny Abraham, Anil Shinde and Ramkumar Subramanian and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Alzheimer s & Dementia.

In The Last Decade

Nageswararao Muddana

30 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nageswararao Muddana India	12	137	75	71	61	40	30	350
Katelijne Anciaux Belgium	6	182 1.3×	66 0.9×	97 1.4×	39 0.6×	36 0.9×	8	459
Klaus Klinder Germany	13	143 1.0×	89 1.2×	55 0.8×	29 0.5×	90 2.3×	15	419
Ahmad Tarmizi Che Has Malaysia	9	179 1.3×	121 1.6×	36 0.5×	25 0.4×	74 1.9×	22	492
Ryuichi Tsujita Japan	12	157 1.1×	74 1.0×	99 1.4×	67 1.1×	62 1.6×	17	369
Gareth Maher‐Edwards United Kingdom	8	116 0.8×	74 1.0×	147 2.1×	41 0.7×	95 2.4×	16	390
Daniel R. McDougle United States	11	146 1.1×	76 1.0×	107 1.5×	20 0.3×	58 1.4×	15	413
Anna Staniszewski United States	4	163 1.2×	52 0.7×	98 1.4×	22 0.4×	94 2.4×	5	274
Henrik Tang Vestergaard Denmark	12	165 1.2×	120 1.6×	27 0.4×	114 1.9×	32 0.8×	15	417
Edijs Vavers Latvia	14	263 1.9×	127 1.7×	38 0.5×	27 0.4×	49 1.2×	30	455
С. В. Логвинов Russia	10	157 1.1×	59 0.8×	39 0.5×	26 0.4×	144 3.6×	84	425

Countries citing papers authored by Nageswararao Muddana

Since Specialization

Citations

This map shows the geographic impact of Nageswararao Muddana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nageswararao Muddana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nageswararao Muddana more than expected).

Fields of papers citing papers by Nageswararao Muddana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nageswararao Muddana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nageswararao Muddana. The network helps show where Nageswararao Muddana may publish in the future.

Co-authorship network of co-authors of Nageswararao Muddana

This figure shows the co-authorship network connecting the top 25 collaborators of Nageswararao Muddana. A scholar is included among the top collaborators of Nageswararao Muddana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nageswararao Muddana. Nageswararao Muddana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nirogi, Ramakrishna, Renny Abraham, Vijay Benade, et al.. (2018). SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization. Behavioural Pharmacology. 30(1). 16–35. 30 indexed citations

Nirogi, Ramakrishna, Koteshwara Mudigonda, Gopinadh Bhyrapuneni, et al.. (2016). P1‐085: SUVN‐502, Potent and Pure 5‐HT₆ Receptor Antagonist: Proof‐of‐Concept Study Design in Moderate Alzheimer’s Disease Patients. Alzheimer s & Dementia. 12(7S_Part_9). 2 indexed citations

Jayarajan, Pradeep, Gopinadh Bhyrapuneni, Koteshwara Mudigonda, et al.. (2016). P3‐016: SUVN‐D4010, A Potent and Selective 5‐HT₄ Receptor Partial Agonist: Safety, Tolerability and Pharmacokinetics in Humans. Alzheimer s & Dementia. 12(7S_Part_17). 3 indexed citations

Bhyrapuneni, Gopinadh, Koteshwara Mudigonda, Veera Raghava Chowdary Palacharla, et al.. (2016). P2‐026: SUVN‐G3031, a Potent and Selective H3 Receptor Inverse Agonist: Safety, Tolerability and Pharmacokinetics in Humans. Alzheimer s & Dementia. 12(7S_Part_12). 2 indexed citations

Jayarajan, Pradeep, Renny Abraham, Gopinadh Bhyrapuneni, et al.. (2015). P1‐302: 5‐ht₆ antagonist SUVN‐502 potentiates the procognitive and neurochemical effects of donepezil and memantine. Alzheimer s & Dementia. 11(7S_Part_10). 2 indexed citations

Nirogi, Ramakrishna, Koteshwara Mudigonda, Gopinadh Bhyrapuneni, et al.. (2015). P3‐296: Safety, tolerability, and pharmacokinetics of a potent and selective 5‐ht₆ receptor antagonist, SUVN‐502, following multiple ascending doses in healthy elderly subjects, and effect of gender and food on single‐dose pharmacokinetics. Alzheimer s & Dementia. 11(7S_Part_16). 2 indexed citations

Muddana, Nageswararao, et al.. (2014). P1‐397: SUVN‐G3031: A NOVEL AND POTENT HISTAMINE H3 RECEPTOR ANTAGONIST FOR POTENTIAL TREATMENT OF COGNITIVE DEFICITS. Alzheimer s & Dementia. 10(4S_Part_11). 2 indexed citations

Nirogi, Ramakrishna, Vishwottam Kandikere, Pradeep Jayarajan, et al.. (2013). Aripiprazole in an Animal Model of Chronic Alcohol Consumption and Dopamine D₂Receptor Occupancy in Rats. The American Journal of Drug and Alcohol Abuse. 39(2). 72–79. 11 indexed citations

Nirogi, Ramakrishna, Renny Abraham, Pradeep Jayarajan, et al.. (2012). Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task. Brain Research. 1453. 40–45. 15 indexed citations

10.

Nirogi, Ramakrishna, et al.. (2012). Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N1-arylsulfonyl indole derivatives as 5-HT6 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 22(24). 7431–7435. 8 indexed citations

11.

Nirogi, Ramakrishna, Gopinadh Bhyrapuneni, Vishwottam Kandikere, et al.. (2012). Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats. European Journal of Drug Metabolism and Pharmacokinetics. 37(3). 155–161. 16 indexed citations

12.

Nirogi, Ramakrishna, et al.. (2012). Rat thalamic α4β2 neuronal nicotinic acetylcholine receptor occupancy assay using LC–MS/MS. Journal of Pharmacological and Toxicological Methods. 65(3). 136–141. 7 indexed citations

13.

Nirogi, Ramakrishna, et al.. (2012). In vivo receptor occupancy assay of histamine H3 receptor antagonist in rats using non-radiolabeled tracer. Journal of Pharmacological and Toxicological Methods. 65(3). 115–121. 12 indexed citations

14.

Nirogi, Ramakrishna, Vishwottam Kandikere, Gopinadh Bhyrapuneni, et al.. (2012). Methyllycaconitine: A non-radiolabeled ligand for mapping α7 neuronal nicotinic acetylcholine receptors — In vivo target localization and biodistribution in rat brain. Journal of Pharmacological and Toxicological Methods. 66(1). 22–28. 8 indexed citations

15.

Nirogi, Ramakrishna, Anil Shinde, Ramkumar Subramanian, et al.. (2012). Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT₆Receptor Antagonists. Journal of Medicinal Chemistry. 55(21). 9255–9269. 13 indexed citations

16.

Nirogi, Ramakrishna, Vishwottam Kandikere, Gopinadh Bhyrapuneni, et al.. (2012). Approach to reduce the non-specific binding in microdialysis. Journal of Neuroscience Methods. 209(2). 379–387. 23 indexed citations

17.

Nirogi, Ramakrishna, Gopinadh Bhyrapuneni, Vishwottam Kandikere, et al.. (2012). Pharmacokinetic profiling of efavirenz–emtricitabine–tenofovir fixed dose combination in pregnant and non‐pregnant rats. Biopharmaceutics & Drug Disposition. 33(5). 265–277. 14 indexed citations

18.

Nirogi, Ramakrishna, Vishwottam Kandikere, Prashanth Komarneni, et al.. (2011). Quantification of methyllycaconitine, selective α₇ nicotinic receptor antagonist, in rodent plasma and brain tissue by liquid chromatography tandem mass spectrometry – application to neuropharmacokinetics of methyllycaconitine in rats. Biomedical Chromatography. 25(11). 1273–1282. 3 indexed citations

19.

Bhyrapuneni, Gopinadh, Nageswararao Muddana, Vijay Benade, et al.. (2008). P2‐415: The 5‐HT₆ receptor antagonist SUVN‐502 enhances acetylcholine and glutamate in rat ventral hippocampus and frontal cortex: A microdialysis study. Alzheimer s & Dementia. 4(4S_Part_15). 1 indexed citations

20.

Nirogi, Ramakrishna, Vishwottam Kandikere, Koteshwara Mudigonda, et al.. (2008). A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. Journal of Neuroscience Methods. 178(1). 116–119. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact